Two Reasons Osimertinib in 1st Line Good Toxicity Profile & amp; Crossing Blood Brain Barrier

Anne S. Tsao, MD of MD Anderson Cancer Center discusses two reasons Osimertinib is good for first line treatment such as it's good toxicity profile and how it crosses the blood brain barrier from the ... Author: thoraciconcology Added: 12/29/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts